Biologicals: finished product
Biologicals: finished product
Biologicals: finished product
Stakeholder workshop on support to quality development in early access approaches, such as PRIME and Breakthrough Therapies, European Medicines Agency, Amsterdam, the Netherlands, 26 November 2018
Human medicines European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Mylan), clopidogrel, Date of authorisation: 21/09/2009, Revision: 21, Status: Authorised
Notification of discontinuation of an agreed PIP decision
Scientific advice and protocol assistance adopted during the CHMP meeting 11-14 December 2023
Member states contact points for translations review
Scientific and technical recommendations: Veterinary Medicines Regulation
Draft guideline on the evaluation of the benefit-risk balance of veterinary medicinal products
Comirnaty : Periodic safety update report assessment 19 June 2022 to 18 December 2022
Vaxzevria: Periodic safety update report assessment 29 December 2021 to 28 June 2022